Orlistat, an antiobesity drug with well-documented efficacy in weight reduction and maintenance, has beneficial effects on metabolic variables. It reduces the incidence of Type 2 diabetes in ...
In February 2023, a different drug, orlistat, was approved in Japan as the first over-the-counter medicine for the reduction of visceral fat in the treatment of obesity. Orlistat is a lipase ...